Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
IOGPQ
|
Jamey S Seely
EVP-Gen Counsel & Corp Sec'y |
BUY
Grant, award, or other acquisition
|
Direct | 25,000 Added 40.24% |
-
|
Mar 01
2016 |
IOGPQ
|
Colin Hulme
EVP, Ocean Bottom Services |
BUY
Grant, award, or other acquisition
|
Direct | 12,500 Added 41.39% |
-
|
Mar 01
2016 |
IOGPQ
|
Scott Schwausch
VP, Finance & Corp Controller |
BUY
Grant, award, or other acquisition
|
Direct | 2,000 Added 38.79% |
-
|
Mar 01
2016 |
IOGPQ
|
Christopher Theron Usher
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 343 Reduced 1.82% |
$1,063
$3.1 p/Share
|
Mar 01
2016 |
IOGPQ
|
Christopher Theron Usher
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 12,500 Added 39.82% |
-
|
Mar 01
2016 |
IOGPQ
|
Ken Williamson
EVP, Innov & Strat Mktg |
BUY
Grant, award, or other acquisition
|
Direct | 17,500 Added 36.92% |
-
|
Mar 01
2016 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 2.17% |
-
|
Mar 01
2016 |
IOGPQ
|
David H Barr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 19.33% |
-
|
Mar 01
2016 |
IOGPQ
|
Huimin Hao
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 23.8% |
-
|
Mar 01
2016 |
IOGPQ
|
Huimin Hao
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 500 Reduced 8.33% |
$1,550
$3.1 p/Share
|
Mar 01
2016 |
IOGPQ
|
Michael Jennings
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 19.33% |
-
|
Mar 01
2016 |
IOGPQ
|
Franklin Myers
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 8.89% |
-
|
Mar 01
2016 |
IOGPQ
|
S James Nelson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 17.52% |
-
|
Mar 01
2016 |
IOGPQ
|
John N Seitz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 15.38% |
-
|
Mar 01
2016 |
BW
|
Blue Harbour Group, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 0.76% |
$755,200
$18.88 p/Share
|
Mar 01
2016 |
BW
|
Blue Harbour Group, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,700 Reduced 0.49% |
$489,585
$19.05 p/Share
|
Mar 01
2016 |
LOW
|
Sandra B Cochran
Director |
BUY
Open market or private purchase
|
Direct | 1,500 Added 50.0% |
$100,965
$67.31 p/Share
|
Mar 01
2016 |
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 22,422 Reduced 1.78% |
$1,941,745
$86.6 p/Share
|
Mar 01
2016 |
ADBE
|
Shantanu Narayen
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 22,422 Added 6.52% |
$763,021
$34.03 p/Share
|
Mar 01
2016 |
CMCSA
|
Lawrence J Salva
EVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 18,732 Reduced 21.03% |
$1,105,375
$59.01 p/Share
|
Mar 01
2016 |
CMCSA
|
Lawrence J Salva
EVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 33,222 Added 27.17% |
$527,898
$15.89 p/Share
|
Mar 01
2016 |
CMCSA
|
Lawrence J Salva
EVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 48,044 Reduced 68.31% |
$2,837,959
$59.07 p/Share
|
Mar 01
2016 |
TMO
|
Seth H Hoogasian
Sr. VP & Retiring Gen. Counsel |
SELL
Open market or private sale
|
Direct | 2,951 Reduced 7.4% |
$398,385
$135.0 p/Share
|
Mar 01
2016 |
SYNH
|
Michael Gibertini |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 15.99% |
$358,650
$39.85 p/Share
|
Mar 01
2016 |
SYNH
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct | 9,000 Added 13.79% |
$76,050
$8.45 p/Share
|
Mar 01
2016 |
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.4% |
$94,560
$94.56 p/Share
|
Mar 01
2016 |
SNX
|
Simon Leung
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 3.35% |
$94,720
$94.72 p/Share
|
Mar 01
2016 |
SPOK
|
Vincent D Kelly
President & CEO |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 1.49% |
$88,350
$17.67 p/Share
|
Mar 01
2016 |
IRDM
|
Thomas C Canfield |
BUY
Open market or private purchase
|
Direct | 5,000 Added 2.55% |
$34,750
$6.95 p/Share
|
Mar 01
2016 |
IOGPQ
|
R Brian Hanson
President & CEO |
BUY
Open market or private purchase
|
Direct | 20,000 Added 15.36% |
$76,800
$3.84 p/Share
|
Mar 01
2016 |
IOGPQ
|
R Brian Hanson
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 50,000 Added 35.67% |
-
|
Mar 01
2016 |
IOGPQ
|
Steven Bate
EVP & CFO |
BUY
Open market or private purchase
|
Direct | 10,000 Added 14.62% |
$42,000
$4.2 p/Share
|
Mar 01
2016 |
IOGPQ
|
Steven Bate
EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 25,000 Added 34.05% |
-
|
Mar 01
2016 |
HON
|
Thomas A Szlosek
SVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 27,602 Reduced 30.3% |
$2,886,893
$104.59 p/Share
|
Mar 01
2016 |
HON
|
Thomas A Szlosek
SVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 54,206 Added 37.31% |
$5,669,405
$104.59 p/Share
|
Mar 01
2016 |
ABBV
|
Timothy J. Richmond
EVP, CHIEF HR OFFICER |
SELL
Open market or private sale
|
Direct | 10,792 Reduced 14.02% |
$593,560
$55.0 p/Share
|
Mar 01
2016 |
MA
|
Andrea L Forster
Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct | 2,276 Added 15.31% |
-
|
Mar 01
2016 |
PLXS
|
Dean A Foate
Director |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 3.73% |
$257,600
$36.8 p/Share
|
Mar 01
2016 |
PLXS
|
Dean A Foate
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 7,000 Added 3.59% |
$155,190
$22.17 p/Share
|
Mar 01
2016 |
KMF
|
Voya Financial, Inc.
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 50,000 Reduced 12.5% |
$1,287,500
$25.75 p/Share
|
Feb 29
2016 |
AMT
|
Samme L Thompson |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 35.57% |
$904,300
$90.43 p/Share
|
Feb 29
2016 |
AMT
|
Samme L Thompson |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 26.24% |
$315,000
$31.5 p/Share
|
Feb 29
2016 |
AMT
|
Carolyn Katz
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 32.47% |
$315,000
$31.5 p/Share
|
Feb 29
2016 |
HON
|
Darius Adamczyk
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5,379 Reduced 16.97% |
$553,499
$102.9 p/Share
|
Feb 29
2016 |
HON
|
Darius Adamczyk
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,572 Added 25.01% |
$1,087,859
$102.9 p/Share
|
Feb 29
2016 |
HON
|
Thomas A Szlosek
SVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,378 Reduced 12.73% |
$553,396
$102.9 p/Share
|
Feb 29
2016 |
HON
|
Thomas A Szlosek
SVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,572 Added 20.01% |
$1,087,859
$102.9 p/Share
|
Feb 29
2016 |
CVS
|
Jonathan C Roberts
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16,748 Added 15.39% |
$1,627,403
$97.17 p/Share
|
Feb 29
2016 |
CVS
|
Andrew Sussman
EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct | 1,675 Added 17.11% |
$162,760
$97.17 p/Share
|
Feb 29
2016 |
CVS
|
Andrew Sussman
EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct | 5,024 Added 26.57% |
$488,182
$97.17 p/Share
|
Feb 29
2016 |